Cancer :: First Head n Neck Cancer Treatment with Erbitux

The Food and Drug Administration (FDA) announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck (SCCHN) that can not be removed by surgery (unresectable SCCHN). This is the first drug approved for head and neck cancer that has shown a survival benefit in this population. Erbitux was also approved today for use alone (monotherapy) to treat patients whose head and neck cancer has spread (metastasized) despite the use of standard chemotherapy.

Depression :: Emsam – Selegiline as First Drug Patch for Depression

The Food and Drug Administration approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression. The once a day patch works by delivering selegiline, a monoamine oxidase inhibitor or MAOI, through the skin and into the bloodstream. At its lowest strength, Emsam can be used without the dietary restrictions that are needed for all oral MAO inhibitors that are approved for treating major depression.

Spider Veins :: Four methods to treat Spider Veins

Spider veins can be treated using various methods, depending on the width, location and severity of the veins. While many medical spas reserve a space on their menu one treatment method, few have assembled more. The Skin Rejuvenation Clinic, P.A. offers four effective treatments to tackle spider veins on the face or legs.

Dupuytren’s Disease :: What is Dupuytren’s Disease?

Dupuytren’s (pronounced DOO-puh-trehns) is a connective tissue disease that affects one or both hands. The disease cuased raised nodules and dimples in the skin of the palm that eventually tighten and begin to pull the fingers into a bent position.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack